A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.


Updates from The Motley Fool

Latest updates on Opexa Therapeutics from Fool.com.


Stock Performance

OPXA vs. S&P 500 | 2 Year Performance
View Interactive OPXA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Opexa Therapeutics.
Current Price: $3.27
Prev Close: $3.29
Open: $3.27
Bid: $2.80
Ask: $3.41
Day's Range: $3.21 - $3.39
52wk Range: $1.69 - $5.10
Volume: 10,847
Avg Vol 66,830
Market Cap: $22.45M
P/E (ttm): -2.61
EPS (ttm): -$1.26
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Opexa Therapeutics.
CAPS Rating 1 out of 5
 
35 Outperform
10 Underperform
CAPS All Stars
 
8 Outperform
5 Underperform

How do you think Opexa Therapeutics will perform against the market?



You pick for Opexa Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Neil K. Warma, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Opexa Therapeutics.

A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers